Phase Ib Study Of Venadaparib, A Potent And Selective Parp Inhibitor, In Homologous Recombination Repair (Hrr) Mutated Breast CancerS-A. Im, J. E. Kim,K. S. Lee, Y. W. Moon, H. K. Ahn, C-Y. Ock,E-J. Roh,M. Lee, M. J. Hong, S. Song,K-H. Lee,W. S. LeeANNALS OF ONCOLOGY（2021）引用 1|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
